Kym F. Faull

University of California, Los Angeles — United States

Chemistry · Physical Sciences

75h-index23.2kcitations414works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mass Spectrometry Techniques and Applications(43), Advanced Proteomics Techniques and Applications(27), Glycosylation and Glycoproteins Research(24), Neuroscience and Neuropharmacology Research(20), Metabolomics and Mass Spectrometry Studies(19)

Publications414 total

Correction to “Evidence for Endogenous Collagen in <i>Edmontosaurus</i> Fossil Bone”
Analytical Chemistry·2025Open Access
Evidence for Endogenous Collagen in <i>Edmontosaurus</i> Fossil Bone
Analytical Chemistry·2025· 3 citedOpen Access
Peptide-Charting Applied to Studies of Precursor Processing in Endocrine Tissues
2024
Multiple techniques confirm endogenous collagen in Edmontosaurus fossil bone
2024Open Access
FTIR, XPol, and LC-MS confirm endogenous collagen in Edmontosaurus fossil bone
2023Open Access
Gut microbiota Turicibacter strains differentially modify bile acids and host lipids
Nature Communications·2023· 270 citedOpen Access
Tissue-engineered vocal fold replacement in swine: Methods for functional and structural analysis
PLoS ONE·2023· 8 citedOpen Access
Improved Chromatography and MS-Based Detection of Glyphosate and Aminomethylphosphonic Acid Using iTrEnDi
Journal of the American Society for Mass Spectrometry·2023· 14 cited
Supplementary Figure 1 from Low Levels of Circulating Estrogen Sensitize PTEN-Null Endometrial Tumors to PARP Inhibition &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
Supplementary Methods, Figure Legend, Table 1 from Low Levels of Circulating Estrogen Sensitize PTEN-Null Endometrial Tumors to PARP Inhibition &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
Data from Low Levels of Circulating Estrogen Sensitize PTEN-Null Endometrial Tumors to PARP Inhibition &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
Supplementary Figure 4 from Low Levels of Circulating Estrogen Sensitize PTEN-Null Endometrial Tumors to PARP Inhibition &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
Supplementary Figure 1 from Low Levels of Circulating Estrogen Sensitize PTEN-Null Endometrial Tumors to PARP Inhibition &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
Supplementary Methods, Figure Legend, Table 1 from Low Levels of Circulating Estrogen Sensitize PTEN-Null Endometrial Tumors to PARP Inhibition &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
Data from Low Levels of Circulating Estrogen Sensitize PTEN-Null Endometrial Tumors to PARP Inhibition &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
Supplementary Figure 5 from Low Levels of Circulating Estrogen Sensitize PTEN-Null Endometrial Tumors to PARP Inhibition &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
Supplementary Figure 2 from Low Levels of Circulating Estrogen Sensitize PTEN-Null Endometrial Tumors to PARP Inhibition &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
Supplementary Figure 3 from Low Levels of Circulating Estrogen Sensitize PTEN-Null Endometrial Tumors to PARP Inhibition &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
Supplementary Figure 4 from Low Levels of Circulating Estrogen Sensitize PTEN-Null Endometrial Tumors to PARP Inhibition &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
Supplementary Figure 2 from Low Levels of Circulating Estrogen Sensitize PTEN-Null Endometrial Tumors to PARP Inhibition &lt;i&gt;In Vivo&lt;/i&gt;
2023Open Access
page 1 of 21Next →

Frequent Co-authors

Julian P. Whitelegge(8), Ganesamoorthy Subbanagounder(7), Judith A. Berliner(7), Thuc T. Le(7), Alan M. Fogelman(6), Olaf Schneewind(5), Andrew D. Watson(4), Norbert Leitinger(4), Mohamad Navab(4), Michael E. Jung(4), Hung Ton‐That(4), Susan Hama(3), Joseph L. Witztum(3), Meelad M. Dawlaty(3), Albert W. Cheng(3), Rudolf Jaenisch(3), Guoping Fan(3), Dawn C. Schwenke(2), Srinivasa T. Reddy(2), R Chin(2)